OpenFilings

Unicycive Therapeutics, Inc.

Form8-K

Report Period2025-11-14

Date Filed2025-11-14

Time Filed17:10:14

Document Analysis

Natural Language Processing

Recognized Type Unidentified

Defined Term Format

Exhibits

CURRENT REPORT
AMENDMENT NO. 1 TO SALES AGREEMENT, DATED NOVEMBER 14, 2025, BETWEEN UNICYCIVE T
OPINION OF SHEPPARD MULLIN RICHTER & HAMPTON LLP
Filing on SEC Edgar